-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
On 17 March 2020 the Cabinet of Ministers adopted new amendments to Cabinet Regulation No. 416 “Procedures Regarding the Distribution and Quality Control of Medicinal Products”. The amendments came into force on 31 March 2020. However, some of them will be coming into force later, by 1 July 2021 latest. The amendments are aimed at […]
-
Publication / Aušrinė Dambrauskaitė, Erika Žigutė
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Lithuania specifically targeted at Life Sciences companies. Wholesale distributors of medicinal products must regularly report on available stocks of unsold medicinal products. Due to the state of emergency in the country in relation to COVID-19, wholesale […]
-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Latvia specifically targeted at Life Sciences companies. The government has issued an order limiting export of pharmaceuticals necessary for treatment of Covid-19. The State Medicines Agency will publish a list of pharmaceuticals on its website based […]
-
Publication / Marina Golovnitskaya, Yauheni Budchanka
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Belarus specifically targeted at Life Sciences companies. The government has banned export of some medical goods until at least 1 June: respirators, chemical protection suits, bandages, cotton wool, gauze, medical gloves and masks, etc. The Ministry of […]
-
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Estonia specifically targeted at Life Sciences companies. A draft law is currently pending in the Estonian parliament which foresees many changes to the law due to the Covid-19 crisis. Among others, the Medicinal Products Act is […]
